Press releases
MGC Pharmaceuticals Ltd Announces Completion Of CimetrA Mechanism Of Action Study
PRESS RELEASE Key Highlights: MGC Pharma has completed an in-vitro pre-clinical study on CimetrA™’s mechanism of action (MoA) The study, which was carried out at the GLP-Certified Science in Action Lab, in Ness Ziona, Israel, examined the mechanism underlying the CimetrA™-mediated anti-inflammatory effect on human Peripheral Blood Mononuclear Cells (PBMC) The study demonstrated the inhibitory…
